focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
This could move either direction tomorrow and I wouldn't be surprised. If I had to make a guess, I would expect short term traders moving out causing the usual drop - followed by a steady rise back above the opening price as stronger medium term money continues to move in.
Bojo has told us which direction we're heading in with regards testing and Avacta appear to be the only company who can deliver it - BUT it's not going to happen immediately so expect the rainbow chasers to sell out and return later (if they can even manage to get their hands on any shares when this inevitably blows up!)
I suspect there will be a drop and a churn of shares first thing. Difficult one to call, but with what we know - the short term share price movements are not of much importance (even though we all hate a red day).
Tony, I think you make a fair point here.
If the Government are going to spend billions on rapid tests and distribute them to households - to get the full benefit it must be in some way linked to an app which can record data and prevent cheating. With a lab test, this isn't such an obstacle. Recording results of a test which is carried out in the general publics own homes has obvious pitfalls. This can however be overcome with things such as QR codes, facial recognition and video.
Tomorrow will be short term traders selling and serious investers buying. Which side will be stronger, we do not know.
What we do know is the Gov's only option is rapid testing. We also know Avacta are the only LFA being evaluated on CONDOR. Finally, we know there's two major manufactures preparing to produce our test on mass.
In addition, to our collective knowledge, there isn't a saliva LFA which is more advanced than ours.
Listening to Boris' speech tonight, it's a pretty straight line to Avacta!
Not sure that's a fair comment re placing monies. The LFA will improve Avactas balance sheet significantly and prove the Affimer Platform.
“As we set out in the use of proceeds at the recent fund raising, we have now expanded our product development team with the appointment of an experienced in-vitro diagnostic Product Development Manager and we are expanding the protein production facilities in order to meet the expected demand for Affimer proteins the coronavirus tests and future diagnostic tests in the pipeline."
In terms of delay... All we know for sure is...
1: Avacta haven't failed because if this were the case market would have been informed.
2: It's currently out of Avactas hands and we are waiting on third parties.
Without a way of instantly determining who has Covid and who just has a normal winter bug - we are all up the creek without a paddle and there's no hope of normality until the spring. I still don't think a lot of poeple have realised this because coughs, colds and flu haven't arrived yet...
Any lab based test is unable to meet this need. It's a LFA or nothing as far as I can see. We don't know of any company beyond Avacta who are better placed to deliver one (and in the required quanitities). And of course... Avacta are the only LFA on CONDOR...
As others have pointed out, previous RNS can be taken as accurate until a later RNS says otherwise. No news is good news. If it had gone horribly wrong, we would've been informed.
Well said. The money went piling into Covid stocks earlier this year. It would be reasonable to expect the same will happen again.
In anticipation of Monday's presentation, and also therefore the strong possibility of an RNS beforehand, I think we'll see a lot of buyers moving in as the week progresses. I wouldn't be surpised to see us back at the 180 level.
Very stange to see us down today. I suspect there is indeed an order being filled at the expense of panicked PI's.
There's more pressure than ever for the Goverment to deliver, an investor presentation in one weeks time and as xyz correctly pointed out, a whole load of potential news on the horizon. Neither the fundamentals nor the charts suggest we should be down at this level.
I think it's a strong possbility we'll see more money moving into Covid stocks like we saw back in April. Hopefully we'll get the benefit of this soon.
I haven't read any posts here over the weekend, just having a quick read of the recent ones for the past hour.
My expectation has always been that initially the Awacta LFA tests would be marked for professional use only, with consumers to follow. I can't remember where I got this from, but I believe it has been indicated at some point. I have a feeling it might have been a comment passed in the Cytiva/Awacta car crash webinar but I can't remember for certain.
With the desperate demand for tests, I don't know whether this will now be the case? I wouldn't be surprised by either outcome.
daveb1
Don't take it personally. Going back a little while we had endless new posters signing up and trying to cause problems. It's less common at present, but there's still the odd ones appearing and giving it a try.
Anybody who signs up and opens with something negative or silly will by default be treated like a de-ramper/general idiot as patience is already thin with many of the longer standing posters on this board.
Essentially any new poster is viewed negatively until they prove themselves otherwise. The only way around that is to correctly refer to the company as 'Awacta' and then we'll automically like you.
Anyway, I hope you haven't been scared off and that you are a good addition to the awct board.